Wolverine Trading, LLC Vertex Pharmaceuticals Inc Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $2.16 Million - $2.38 Million	-4,700 Reduced 6.58%	66,700 $31 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $1.41 Million - $1.75 Million	3,600 Added 5.31%	71,400 $33.5 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $5.3 Million - $5.8 Million	13,000 Added 23.72%	67,800 $28.3 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $8.09 Million - $9.69 Million	23,600 Added 75.64%	54,800 $22.3 Million
Q3 2023 Nov 15, 2023	BUY	$338.18 - $362.46 $1.59 Million - $1.7 Million	4,700 Added 17.74%	31,200 $10.8 Million
Q2 2023 Aug 23, 2023	BUY	$314.42 - $351.91 $2.04 Million - $2.29 Million	6,500 Added 32.5%	26,500 $9.33 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $962,982 - $1.1 Million	-3,400 Reduced 14.53%	20,000 $6.24 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $2.23 Million - $2.51 Million	-7,800 Reduced 25.0%	23,400 $6.76 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $1.42 Million - $1.59 Million	5,200 Added 20.0%	31,200 $9.14 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $1.17 Million - $1.46 Million	-5,000 Reduced 16.13%	26,000 $7.29 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $1.7 Million - $2.01 Million	-7,700 Reduced 19.9%	31,000 $7.95 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $2.04 Million - $2.57 Million	11,500 Added 42.28%	38,700 $8.61 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $1.45 Million - $1.62 Million	-8,000 Reduced 22.73%	27,200 $4.96 Million
Q2 2021 Aug 06, 2021	BUY	$187.49 - $221.1 $3.54 Million - $4.18 Million	18,900 Added 115.95%	35,200 $6.93 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $5.96 Million - $6.95 Million	-28,800 Reduced 63.86%	16,300 $3.47 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $1.04 Million - $1.38 Million	5,000 Added 12.47%	45,100 $10.5 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $945,905 - $1.12 Million	-3,700 Reduced 8.45%	40,100 $10.8 Million
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $7.19 Million - $9.44 Million	-31,900 Reduced 42.14%	43,800 $12.5 Million
Q1 2020 May 11, 2020	SELL	$199.77 - $247.81 $4.83 Million - $6 Million	-24,200 Reduced 24.22%	75,700 $17.6 Million
Q4 2019 Feb 12, 2020	BUY	$166.71 - $223.91 $3.25 Million - $4.37 Million	19,500 Added 24.25%	99,900 $21.9 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $1.16 Million - $1.31 Million	-7,000 Reduced 8.01%	80,400 $13.4 Million
Q2 2019 Aug 20, 2019	BUY	$164.61 - $190.37 $2.93 Million - $3.39 Million	17,800 Added 25.57%	87,400 $16 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $1.6 Million - $1.91 Million	9,800 Added 16.39%	69,600 $12.8 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $3.01 Million - $3.81 Million	-19,800 Reduced 24.87%	59,800 $9.65 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $10.9 Million - $12.5 Million	65,000 Added 445.21%	79,600 $15.3 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $2.06 Million - $2.41 Million	-13,600 Reduced 48.23%	14,600 $2.38 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $3.98 Million - $4.51 Million	-29,000 Reduced 50.7%	28,200 $4.23 Million
Q3 2017 Nov 15, 2017	BUY	$148.13 - $162.24 $8.47 Million - $9.28 Million	57,200	57,200 $8.7 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$10.7 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$9.2 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$8.47 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$4.69 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$3.58 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account